Riskpilot← Back to searchSign inGet full accessGENOMICA AB
ABIn liquidationOrg 5569193278Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20130 employees
Revenue 2022
SEK 1,5M
-63% vs 2021
EBITDA margin
53.8%
+1418% vs 2021
Equity ratio
92.8%
Financial strength
Net profit 2022
SEK 1M
+25975% vs 2021
| Revenue | SEK 1,5M | -63% |
| EBITDA | SEK 791K | +1418% |
| Net profit | SEK 1M | +25975% |
| Total assets | SEK 4,3M | +10% |
| Equity | SEK 4M | +35% |
| Employees | 0 | — |
Legal name
GENOMICA AB
Org number
5569193278
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
17 januari 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget har till föremål för sin verksamhet forskning, utveckling, produktion och marknadsföring av alla typer av diagnostisk och identifieringstekniker, system och utrustning, tillika alla andra behjälpliga medel för legal medicin, för människor eller djur och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 4 917 | 6 009 | 12 436 | 3 998 | 1 471 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −358 | 1 089 | 3 062 | −60 | 791 |
| Depreciation & amort. | −230 | −186 | −228 | −0 | −0 |
| EBIT | −588 | 903 | 2 834 | −60 | 791 |
| Net financials | −1 | −2 | — | — | −4 |
| Profit before tax | −588 | 901 | 2 254 | −4 | 1 311 |
| Tax | −0 | −0 | −372 | −0 | −276 |
| Net profit | −588 | 901 | 1 882 | −4 | 1 035 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 654 | 1 488 | 5 121 | 3 898 | 4 269 |
| Equity | 146 | 1 048 | 2 930 | 2 925 | 3 961 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 508 | 441 | 1 611 | 448 | 308 |
| Total debt | 1 508 | 441 | 1 611 | 448 | 308 |
EBITDA margin
53.8%
This company
15.8%
Market median
+241% vs market
20182022
Equity ratio
92.8%
This company
38.2%
Market median
+143% vs market
20182022
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20182022
Net profit margin
70.4%
This company
8.1%
Market median
+769% vs market
20182022
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20182022
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PO Chief Auditor | Chief Auditor | 2021 |
KJ Liquidator | Liquidator | 2020 |
| Former (2) | ||
SP Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
JA Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2023 – 2023 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GENOMICA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sören Peter Jonstrup | Chief Executive Officer | 0 companies |
| Peter Olof Cederblad | Chief Auditor | 0 companies |
| Karl Johan Dietmar Schubert | Liquidator | 0 companies |
| Juan Antonio Bataller | Chief Executive Officer | 0 companies |
| Carlos Maria Galmarini | Board of Directors | 0 companies |
| Jon Uguzne Garay Alonso | Deputy Board Member | 0 companies |
| Luis Sanz Lopez | Deputy Board Member | 0 companies |
| Maria Rosario Cospedal Garcia | Chairman | 0 companies |